143 related articles for article (PubMed ID: 2193641)
41. Cerebral glioma: evaluation with methionine PET.
Ogawa T; Shishido F; Kanno I; Inugami A; Fujita H; Murakami M; Shimosegawa E; Ito H; Hatazawa J; Okudera T
Radiology; 1993 Jan; 186(1):45-53. PubMed ID: 8380108
[TBL] [Abstract][Full Text] [Related]
42. The normal pituitary examined with positron emission tomography and (methyl-11C)-L-methionine and (methyl-11C)-D-methionine.
Bergström M; Muhr C; Ericson K; Lundqvist H; Lilja A; Eriksson L; Blomquist G; Långström B; Johnström P
Neuroradiology; 1987; 29(3):221-5. PubMed ID: 3497360
[TBL] [Abstract][Full Text] [Related]
43. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
44. The role of optimal cut-off diagnosis in 11C-methionine PET for differentiation of intracranial brain tumor from non-neoplastic lesions before treatment.
Yamaki T; Higuchi Y; Yokota H; Iwadate Y; Matsutani T; Hirono S; Sasaki H; Sasao R; Toda M; Onodera S; Oka N; Kobayashi S
Clin Imaging; 2022 Dec; 92():124-130. PubMed ID: 36374712
[TBL] [Abstract][Full Text] [Related]
45. Amino acid study of cerebral gliomas using positron emission tomography--analysis of (11C-methyl)-L-methionine uptake index.
Mineura K; Sasajima T; Suda Y; Kowada M; Shishido F; Uemura K
Neurol Med Chir (Tokyo); 1990 Dec; 30(13):997-1002. PubMed ID: 1714054
[TBL] [Abstract][Full Text] [Related]
46. Primary brain tumors in children.
Naidich TP; Zimmerman RA
Semin Roentgenol; 1984 Apr; 19(2):100-14. PubMed ID: 6328671
[No Abstract] [Full Text] [Related]
47. [Importance of cerebral tomoscintigraphy using technetium-labeled sestamibi in the differential diagnosis of current tumor vs. radiation necrosis in subtentorial glial tumors in the adult].
Lamy-Lhullier C; Dubois F; Blond S; Lecouffe P; Steinling M
Neurochirurgie; 1999 May; 45(2):110-7. PubMed ID: 10448650
[TBL] [Abstract][Full Text] [Related]
48. [Nuclear magnetic resonance tomographic diagnosis of brain tumors in children and adolescents. A comparison with computed tomography].
Gückel C; Benz-Bohm G; Wiedemann G; Thun F
Rofo; 1990 Sep; 153(3):313-20. PubMed ID: 2171066
[TBL] [Abstract][Full Text] [Related]
49. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.
Patronas NJ; Di Chiro G; Brooks RA; DeLaPaz RL; Kornblith PL; Smith BH; Rizzoli HV; Kessler RM; Manning RG; Channing M; Wolf AP; O'Connor CM
Radiology; 1982 Sep; 144(4):885-9. PubMed ID: 6981123
[TBL] [Abstract][Full Text] [Related]
50. [Imaging of pediatric brain tumors using somatostatin analogue 111Ih-DTPA-D-Phe1-octreotide].
Dabasi G; Hauser P; Kertész GP; Balázs G; Karádi Z; Constantin T; Bognár L; Klekner A; Schuler D; Garami M
Magy Onkol; 2007; 51(3):229-34. PubMed ID: 17922063
[TBL] [Abstract][Full Text] [Related]
51. [Utility of 11C-methionine PET/CT in neuro-oncology].
Casas Parera I; Igirio Gamero JL; Blumenkrantz Y; Bruno G; Báez A; Tafur Canabal JG; Báez M; Kuchkaryan V
Medicina (B Aires); 2013; 73(3):201-6. PubMed ID: 23732194
[TBL] [Abstract][Full Text] [Related]
52. The value of
Garcia JR; Cozar M; Baquero M; Fernández Barrionuevo JM; Jaramillo A; Rubio J; Maida G; Soler M; Riera E
Rev Esp Med Nucl Imagen Mol; 2017; 36(2):85-90. PubMed ID: 27503425
[TBL] [Abstract][Full Text] [Related]
53. Posterior cranial fossa tumours in childhood.
Chang T; Teng MM; Lirng JF
Neuroradiology; 1993; 35(4):274-8. PubMed ID: 8492893
[TBL] [Abstract][Full Text] [Related]
54. 11C-MET PET/CT and advanced MRI in the evaluation of tumor recurrence in high-grade gliomas.
D'Souza MM; Sharma R; Jaimini A; Panwar P; Saw S; Kaur P; Mondal A; Mishra A; Tripathi RP
Clin Nucl Med; 2014 Sep; 39(9):791-8. PubMed ID: 25036022
[TBL] [Abstract][Full Text] [Related]
55. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.
Pirotte B; Goldman S; Massager N; David P; Wikler D; Vandesteene A; Salmon I; Brotchi J; Levivier M
J Nucl Med; 2004 Aug; 45(8):1293-8. PubMed ID: 15299051
[TBL] [Abstract][Full Text] [Related]
56. [C-methionine PET in assessment of brain lesions in patients with glial tumors after combined treatment].
Skvortsova TY; Gurchin AF; Savintseva ZI
Zh Vopr Neirokhir Im N N Burdenko; 2019; 83(2):27-36. PubMed ID: 31166315
[TBL] [Abstract][Full Text] [Related]
57. [Clinical application of positron emission tomography and 18FDG to brain tumor].
Momose T
Nihon Rinsho; 2005 Sep; 63 Suppl 9():242-9. PubMed ID: 16201530
[No Abstract] [Full Text] [Related]
58. In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment.
Holthoff VA; Herholz K; Berthold F; Widemann B; Schröder R; Neubauer I; Heiss WD
Cancer; 1993 Aug; 72(4):1394-403. PubMed ID: 8339230
[TBL] [Abstract][Full Text] [Related]
59. Spinal cord ependymoma: a positron emission tomographic study with (11C-methyl)-L-methionine.
Sasajima T; Mineura K; Itoh Y; Kowada M; Hatazawa J; Ogawa T; Uemura K
Neuroradiology; 1996 Jan; 38(1):53-5. PubMed ID: 8773278
[TBL] [Abstract][Full Text] [Related]
60. Computed tomography in the follow-up of medulloblastomas and ependymomas.
Enzmann DR; Norman D; Levin V; Wilson C; Newton TH
Radiology; 1978 Jul; 128(1):57-63. PubMed ID: 663226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
